LipoScience to present at 2010 UBS Global Healthcare Services Conference
(Raleigh, N.C.) LipoScience, Inc., a leading developer of medical diagnostics using proprietary applications of nuclear magnetic resonance (NMR) spectroscopy, announced today that Richard O. Brajer, the company’s President and Chief Executive Officer, will be presenting at the 2010 UBS Global Healthcare Services Conference on Monday, February 8, at 1:30 p.m., EST, at the Grand Hyatt in New York City.
LipoScience, Inc. is a privately held diagnostic company that is focused on developing and marketing clinical diagnostic applications of nuclear magnetic resonance (NMR) spectroscopy in the areas of cardiovascular and other metabolic disorders. The company was founded as a lab service business, and is decentralizing the technology platform to transition into an IVD diagnostic company. LipoScience’s flagship product, the NMR LipoProfile test, is the first NMR-based clinical application that counts and measures lipoprotein particles – microscopic spheres in the blood that carry cholesterol throughout the body – to aid in the management of cardiovascular disease.
For more information, visit www.liposcience.com or www.lipoprofile.com
